The Cooper Companies is a global medical device manufacturer operating through two primary segments: CooperVision, which designs and produces contact lenses for vision correction across diverse customer bases and markets worldwide, and CooperSurgical, which supplies surgical instruments, fertility treatments, contraception products, and women's health services to hospitals, clinics, and medical offices. CooperVision generates revenue by selling branded contact lenses through direct sales teams and distributors to retail optical chains and group practices, while CooperSurgical serves fertility clinics, OB/GYN practices, and hospitals with IVF media, surgical equipment, donor services, and contraceptive products. The company competes on innovation, product quality, technological differentiation, and service reliability in fragmented markets dominated by larger diversified medical device competitors, and captures revenue growth from expanding myopia management adoption, rising infertility treatment demand, and consolidation among healthcare provider networks.